2 completed, 2 not yet recruiting, 2 recruiting, 1 enrolling by invitation. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Enrolling by invitation 1, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Large Vessel Vasculitis: new trials by email Literature Review of Large Vessel Vasculitis trials Research Report on Large Vessel Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study. [18F]FDG Long-Axial Field of View (LAFOV)-PET/CT, CT Angiogram, MR Angiogram - Large Vessel Vasculitis, Takayasu Arteritis | Not applicable | Not yet recruiting | Imperial College London | 18 | 2026-12-01 | 2026-10-16 |
| Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients Secukinumab, Standard of Care (SOC) - Takayasu Arteritis, Large Vessel Vasculitis | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 52 | 2026-04-01 | 2026-03-27 |
| Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. Standard-of-care PET/CT, NeuroEXPLORER - Dementia, Movement Disorders | Not applicable | Enrolling by invitation | prof. dr. Koen Van Laere | 1600 | 2025-09-30 | 2026-05-19 |
| Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) Bosentan and dapagliflozin - Large Vessel Vasculitis, Giant Cell Arteritis (GCA) | Phase 2 | Recruiting | University of Edinburgh | 60 | 2025-03-21 | 2026-01-14 |
| Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System glucocorticoid, immunosuppressants, targeted therapy - Large Vessel Vasculitis | Recruiting | Nanjing Medical University | 150 | 2024-01-01 | 2025-02-13 | |
| Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica. Giant Cell Arteritis, Polymyalgia Rheumatica | Completed | Salome Kristensen | 198 | 2023-08-01 | 2026-04-30 | |
| Monitoring Large Vessel Vasculitis With PET/MR Imaging Large Vessel Vasculitis | Completed | University of Edinburgh | 27 | 2019-07-01 | 2022-05-24 |
Giant Cell Arteritis (3) · Takayasu Arteritis (3) · Amyotrophic Lateral Sclerosis (1) · Brain Neoplasms (1) · Dementia (1) · Epilepsy (1) · Head and Neck Neoplasms (1) · Inflammation (1) · Lewy Body Disease (1) · Movement Disorders (1) · Neuroblastoma (1) · Parathyroid Neoplasms (1) · Parkinson Disease (1) · Pituitary Neoplasms (1) · Polymyalgia Rheumatica (1)
Arteritis (4) · Brain Diseases (4) · Cardiovascular Diseases (4) · Central Nervous System Diseases (4) · Nervous System Diseases (4) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Vascular Diseases (4) · Vasculitis (4) · Aortic Arch Syndromes (3) · Aortic Diseases (3) · Autoimmune Diseases (3) · Autoimmune Diseases of the Nervous System (3) · Cerebrovascular Disorders (3)
Bosentan (1) · Glucocorticoids (1) · Immunosuppressive Agents (1) · Standard of Care (1) · dapagliflozin (1) · secukinumab (1)
University of Edinburgh (2) · Assistance Publique - Hôpitaux de Paris (1) · Imperial College London (1) · Nanjing Medical University (1) · Salome Kristensen (1) · prof. dr. Koen Van Laere (1)
United Kingdom (3) · Belgium (1) · China (1) · Denmark (1)
Neeraj Dhaun, MBChB PhD (1) · Salome Kristensen, MD, PhD (1) · Tara D Barwick, MBChB MSc FRCR FRCP (1) · Taryn Youngstein, BSc MB BS MD (Res) MRCP (1)